These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9835503)

  • 1. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.
    Nicoll AJ; Colledge DL; Toole JJ; Angus PW; Smallwood RA; Locarnini SA
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3130-5. PubMed ID: 9835503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
    Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
    Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.
    Delmas J; Schorr O; Jamard C; Gibbs C; Trépo C; Hantz O; Zoulim F
    Antimicrob Agents Chemother; 2002 Feb; 46(2):425-33. PubMed ID: 11796353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
    Colledge D; Civitico G; Locarnini S; Shaw T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C; Pedersen J; Uren E; Locarnini S
    Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of duck hepatitis B virus in bile duct epithelial cells: implications for pathogenesis and persistent infection.
    Nicoll AJ; Angus PW; Chou ST; Luscombe CA; Smallwood RA; Locarnini SA
    Hepatology; 1997 Feb; 25(2):463-9. PubMed ID: 9021965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
    J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
    Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
    Le Guerhier F; Thermet A; Guerret S; Chevallier M; Jamard C; Gibbs CS; Trépo C; Cova L; Zoulim F
    J Hepatol; 2003 Mar; 38(3):328-34. PubMed ID: 12586299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
    Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
    Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN; Slomka MJ; Maung M
    J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
    J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
    Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li XY; Chen SH; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2000 Jan; 44(1):111-22. PubMed ID: 10602731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver.
    Reaiche-Miller GY; Thorpe M; Low HC; Qiao Q; Scougall CA; Mason WS; Litwin S; Jilbert AR
    Virology; 2013 Nov; 446(1-2):357-64. PubMed ID: 24074600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture.
    Heijtink RA; Kruining J; de Wilde GA; Balzarini J; de Clercq E; Schalm SW
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2180-2. PubMed ID: 7811041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
    Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L
    Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture.
    Hung LF; Brumbaugh AE; Bhatia G; Marion PL; Hung PP; Norbeck DW; Plattner JJ; Robinson WS
    J Med Virol; 1991 Nov; 35(3):180-6. PubMed ID: 1804929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.